OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential detrimental role of soluble ACE2 in severe COVID‐19 comorbid patients
Mahmudur Rahman, Maruf Hasan, Asif Ahmed
Reviews in Medical Virology (2021) Vol. 31, Iss. 5, pp. 1-12
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Role of Hypertension on the Severity of COVID-19: A Review
Mei Peng, Jia He, Ying Xue, et al.
Journal of Cardiovascular Pharmacology (2021) Vol. 78, Iss. 5, pp. e648-e655
Open Access | Times Cited: 121

Oral antiviral treatments for COVID-19: opportunities and challenges
Laila Rahmah, Sunny O. Abarikwu, Amanuel Godana Arero, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1255-1278
Open Access | Times Cited: 70

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 65

HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism
Hayrünnisa Bolay, Ömer Karadaş, Bilgin Öztürk, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 65

ACE2 Shedding and the Role in COVID-19
Jieqiong Wang, Huiying Zhao, Youzhong An
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 64

The impact of Parkinson's disease on manifestations and outcomes of Covid‐19 patients: A systematic review and meta‐analysis
Amr Ehab El‐Qushayri, Sherief Ghozy, Abdullah Reda, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 60

Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection
Henry Daniell, Smruti K. Nair, Nardana Esmaeili, et al.
Molecular Therapy (2021) Vol. 30, Iss. 5, pp. 1966-1978
Open Access | Times Cited: 59

Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization
Luigi di Filippo, Melin Uygur, Massimo Locatelli, et al.
Endocrine (2023) Vol. 80, Iss. 3, pp. 669-683
Open Access | Times Cited: 35

Endotheliopathy in Acute COVID-19 and Long COVID
Alice G. Vassiliou, Charikleia S. Vrettou, Chrysi Keskinidou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8237-8237
Open Access | Times Cited: 30

Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines
Paolo Bellavite, Alessandra Ferraresi, Ciro Isidoro
Biomedicines (2023) Vol. 11, Iss. 2, pp. 451-451
Open Access | Times Cited: 29

Prevalence of oral manifestations in COVID‐19: A systematic review
Preeti Sharma, Sangeeta Malik, Vijay Wadhwan, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 33

Molecular cross-talk between long COVID-19 and Alzheimer’s disease
Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2885-2899
Open Access | Times Cited: 7

Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4464-4464
Open Access | Times Cited: 23

S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 15

The collectrin‐like part of theSARS‐CoV‐1 and ‐2receptorACE2is shed by the metalloproteinasesADAM10andADAM17
Rabea Victoria Niehues, Justyna Wozniak, Florian Wiersch, et al.
The FASEB Journal (2022) Vol. 36, Iss. 3
Open Access | Times Cited: 21

Immune system-related soluble mediators and COVID-19: basic mechanisms and clinical perspectives
Mohammad Sadegh Soltani‐Zangbar, Forough Parhizkar, Mojtaba Abdollahi, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 21

Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses
Mikhail Lebedin, Christoph Ratswohl, Amar K. Garg, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109330-109330
Open Access | Times Cited: 3

COVID-19 and oral lesions: 2020–2024 outpatient case series and literature review
Ana Glavina, Jozo Badrov, Marino Lukenda, et al.
Acta Dermatovenerologica Alpina Pannonica et Adriatica (2024) Vol. 33, Iss. 1
Closed Access | Times Cited: 3

Involvement of the ACE2/Ang-(1–7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19
Taylor Morganstein, Ziyad S. Haidar, Joshua Trivlidis, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12955-12955
Open Access | Times Cited: 20

SheddomeDB 2023: A Revision of an Ectodomain Shedding Database Based on a Comprehensive Literature Review and Online Resources
Wun-Yi Huang, Kun‐Pin Wu
Journal of Proteome Research (2023) Vol. 22, Iss. 8, pp. 2570-2576
Open Access | Times Cited: 7

Role of the RAAS in mediating the pathophysiology of COVID-19
Jakub Jasiczek, Adrian Doroszko, Tymoteusz Trocha, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 3, pp. 475-486
Open Access | Times Cited: 2

SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
Rohan Ameratunga, A. M. Jordan, Klaus Lehnert, et al.
Antiviral Research (2024) Vol. 227, pp. 105894-105894
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top